Hematopoietic Stem Cell Transplantation for Malignant Solid Tumors in Children
作者： Toshihisa Tsuruta
DOI: 10.5772/25848
关键词:
摘要: The prognosis of malignant solid tumors in children has been improved by multidisciplinary therapy involving surgery, radiotherapy and chemotherapy. High-dose chemotherapy (HDC) followed autologous (Auto) or allogeneic (Allo) hematopoietic stem cell transplantation (HSCT) contributed significantly to improvements the high-risk chemosensitive tumors. It utilized many kinds pediatric malignancies, not only but also such as neuroblastoma, brain tumors, Ewing’s sarcoma, osteosarcoma, Wilms’ tumor, rhabdomyosarcoma, hepatoblastoma, retinoblastoma. Fig, 1 shows numbers cases which HSCT was used for Japan. When is patients with there are several treatment objectives. First, it can be intended a curative acting on minimal residual cells after
intechopen.com
sci-hub.st 参考文章(143)
Jon Pritchard, Simon J. Cotterill, Shirley M. Germond, John Imeson, Jan de Kraker, David R. Jones, High dose melphalan in the treatment of advanced neuroblastoma: results of a randomised trial (ENSG-1) by the European Neuroblastoma Study Group. Pediatric Blood & Cancer. ,vol. 44, pp. 348- 357 ,(2005) , 10.1002/PBC.20219
SL Cohn, TJ Moss, M Hoover, HM Katzenstein, PR Haut, ER Morgan, AA Green, M Kletzel, Treatment of poor-risk neuroblastoma patients with high-dose chemotherapy and autologous peripheral stem cell rescue Bone Marrow Transplantation. ,vol. 20, pp. 543- 551 ,(1997) , 10.1038/SJ.BMT.1700932
Sridharan Gururangan, Jeanne Krauser, Melody A. Watral, Tim Driscoll, Nicole Larrier, David A. Reardon, Jeremy N. Rich, Jennifer A. Quinn, James J. Vredenburgh, Annick Desjardins, Roger E. McLendon, Herbert Fuchs, Joanne Kurtzberg, Henry S. Friedman, Efficacy of high-dose chemotherapy or standard salvage therapy in patients with recurrent medulloblastoma. Neuro-oncology. ,vol. 10, pp. 745- 751 ,(2008) , 10.1215/15228517-2008-044
Joanna L. Weinstein, Howard M. Katzenstein, Susan L. Cohn, Advances in the diagnosis and treatment of neuroblastoma Oncologist. ,vol. 8, pp. 278- 292 ,(2003) , 10.1634/THEONCOLOGIST.8-3-278
Gregory A. Yanik, John E. Levine, Katherine K. Matthay, James C. Sisson, Barry L. Shulkin, Brahm Shapiro, David Hubers, Susan Spalding, Tom Braun, James L.M. Ferrara, Raymond J. Hutchinson, Pilot Study of Iodine-131–Metaiodobenzylguanidine in Combination With Myeloablative Chemotherapy and Autologous Stem-Cell Support for the Treatment of Neuroblastoma Journal of Clinical Oncology. ,vol. 20, pp. 2142- 2149 ,(2002) , 10.1200/JCO.2002.08.124
F. Fagioli, M. Aglietta, A. Tienghi, S. Ferrari, A. Brach del Prever, E. Vassallo, A. Palmero, E. Biasin, G. Bacci, P. Picci, E. Madon, High-dose chemotherapy in the treatment of relapsed osteosarcoma: an Italian sarcoma group study. Journal of Clinical Oncology. ,vol. 20, pp. 2150- 2156 ,(2002) , 10.1200/JCO.2002.08.081
M. Carli, R. Colombatti, O. Oberlin, M. Stevens, L. Masiero, E. Frascella, E. Koscielniak, J. Treuner, C. R. Pinkerton, High-Dose Melphalan With Autologous Stem-Cell Rescue in Metastatic Rhabdomyosarcoma Journal of Clinical Oncology. ,vol. 17, pp. 2796- 2803 ,(1999) , 10.1200/JCO.1999.17.9.2796
U. Thiel, A. Wawer, P. Wolf, M. Badoglio, A. Santucci, T. Klingebiel, O. Basu, A. Borkhardt, H.-J. Laws, Y. Kodera, A. Yoshimi, C. Peters, R. Ladenstein, A. Pession, A. Prete, E.-C. Urban, W. Schwinger, P. Bordigoni, A. Salmon, M.A. Diaz, B. Afanasyev, I. Lisukov, E. Morozova, A. Toren, B. Bielorai, J. Korsakas, F. Fagioli, D. Caselli, G. Ehninger, B. Gruhn, U. Dirksen, F. Abdel-Rahman, M. Aglietta, E. Mastrodicasa, M. Torrent, P. Corradini, F. Demeocq, G. Dini, P. Dreger, M. Eyrich, J. Gozdzik, F. Guilhot, E. Holler, E. Koscielniak, C. Messina, D. Nachbaur, R. Sabbatini, E. Oldani, H. Ottinger, H. Ozsahin, R. Schots, S. Siena, J. Stein, S. Sufliarska, A. Unal, M. Ussowicz, P. Schneider, W. Woessmann, H. Jürgens, M. Bregni, S. Burdach, No improvement of survival with reduced- versus high-intensity conditioning for allogeneic stem cell transplants in Ewing tumor patients Annals of Oncology. ,vol. 22, pp. 1614- 1621 ,(2011) , 10.1093/ANNONC/MDQ703
Paul E. Grundy, Norman E. Breslow, Sierra Li, Elizabeth Perlman, J. Bruce Beckwith, Michael L. Ritchey, Robert C. Shamberger, Gerald M. Haase, Giulio J. D'Angio, Milton Donaldson, Max J. Coppes, Marcio Malogolowkin, Patricia Shearer, Patrick R.M. Thomas, Roger Macklis, Gail Tomlinson, Vicki Huff, Daniel M. Green, Loss of Heterozygosity for Chromosomes 1p and 16q Is an Adverse Prognostic Factor in Favorable-Histology Wilms Tumor: A Report From the National Wilms Tumor Study Group Journal of Clinical Oncology. ,vol. 23, pp. 7312- 7321 ,(2005) , 10.1200/JCO.2005.01.2799
G B McCowage, M R Vowels, P J Shaw, L Lockwood, H Mameghan, Autologous bone marrow transplantation for advanced neuroblastoma using teniposide, doxorubicin, melphalan, cisplatin, and total-body irradiation. Journal of Clinical Oncology. ,vol. 13, pp. 2789- 2795 ,(1995) , 10.1200/JCO.1995.13.11.2789